Certara

At #ACoP15, Certara’s thought leadership in Exposure-Response Modeling takes the spotlight with three accepted posters exploring innovative strategies for optimizing treatments by Bill Poland, PhD, and Swati DebRoy, PhD. Be sure to join us at booths #4 & 5 to explore these groundbreaking insights! #ExposureResponse #Pharmacometrics #ClinicalTrials

#CERTAINTY by Certara kicks off tomorrow in Mainz, Germany. We hope to see you there! Discover all the details about the event here: https://lnkd.in/ejDR83h5

Are you ready to enhance your PopPK modeling skills? Whether you prefer the simplicity of a GUI, the flexibility of coding, or a combination of both, this webinar will guide you in building more efficient models. Learn from the experts at Certara! Date: November 21 Time: 10 AM ET Register Now: https://ow.ly/u6Zj50TSHqQ Who Should Attend: Pharmacometricians, modelers, and anyone looking to improve their pharmacokinetic models.

Are you attending the ACT 45th Annual Meeting this November? Don’t miss Peggy Zorn's presentation, where she’ll discuss the benefits and logistics of accessing real-time data from nonclinical studies, along with strategies for building effective data pipelines and utilizing advanced analytics for ongoing research. Make sure to visit us at Booth #216! Discover more about our presence at the conference: https://ow.ly/F8fL50TTzLf #ACTOX2024

Join us at #ACoP15 to explore innovations in Targeted Radiation Therapy! Certara’s new model-informed framework offers a pathway to optimize dose and design safer, more effective targeted radiation therapies amidst a shifting regulatory landscape. See our poster on Monday, November 11th, and meet scientist Hunter Stephens, Ph.D., to learn how we're advancing oncology through precision dosing and therapeutic innovation. Let’s shape the future of oncology—see you there! #RadiationTherapy #Oncology

Get ready to be inspired! We’ve got an exciting Bioanalysis Zone interview coming soon with our own Piet Van Der Graaf, SVP of QSP, fresh from PharmSci 2024! Piet will share some of the hottest topics in AI for pharma: 𝗛𝗼𝘄 𝗵𝗲 𝗴𝗼𝘁 𝘀𝘁𝗮𝗿𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗔𝗜: Discover Piet’s journey and early influences in AI for drug discovery. 𝗣𝗵𝗮𝗿𝗺𝗦𝗰𝗶 𝟮𝟬𝟮𝟰 𝗣𝗹𝗲𝗻𝗮𝗿𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: A recap of his closing plenary, where he’ll share how AI is transforming pharmaceutical discovery. 𝗔𝗜 𝗳𝗼𝗿 𝗔𝘀𝘀𝗮𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: Wondering which AI tools are game-changers for bioanalytical assays? Piet shares his top recommendations! 𝗔𝗱𝘃𝗶𝗰𝗲 𝗳𝗼𝗿 𝗔𝗜 𝗖𝗮𝗿𝗲𝗲𝗿 𝗦𝗲𝗲𝗸𝗲𝗿𝘀: Thinking about making the jump into AI? Piet’s got some expert tips and resources for you. 𝗘𝘃𝗲𝗻𝘁 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: Hear what made PharmSci 2024 unforgettable for him. Follow us to catch the full interview—this one’s packed with insight, innovation, and inspiration! #AIinPharma #PharmSci360

Have you registered for #CERTAINTY by Certara? Join us next week in Mainz, Germany! Don't miss insights from experts Andreas Wallnoefer, Nathalie Wagner, Piet Van Der Graaf, PhD, Simon Westbrook, PhD, Rik de Greef, Justin H., PhD, and william copalu, in our session on the Impact of MIDD and the Role in Decision-Making. Connect with peers and discover how MIDD can transform your approach to drug development. Secure your spot today: https://lnkd.in/ey8Avaub

In this blog, Certara's medical writing experts, Dr. Amy Porter, PhD, ISMPP CMPP and Dr. Holly Capasso-Harris, PhD, ISMPP CMPP™ discuss the essential role of scientific publication professionals. From concept to publication, these specialists ensure your pharmaceutical research is communicated clearly and accurately. Read now: https://ow.ly/yp2350TQ8Bc #ScientificPublishing #MedicalWriting #DrugDevelopment

With more and more clinical trials making use of external vendor data, end-of-study timelines have increased by 32%. Discover strategies to combat these delays and streamline your workflow, from ingestion to validation and submission, with our new best practice guide to managing non-CRF data: https://ow.ly/hzrc50TCsIG

[Announcement] Certara is bringing its premier client summit, #Certainty, to Europe for the first time! Taking place in Mainz, Germany on October 29-30, this two-day event offers exclusive access to Certara’s experts and industry peers to advance drug development and discovery with cutting-edge technology. Designed for pharmacometricians, clinical pharmacologists, regulatory science professionals, biostatisticians, and data scientists, Certainty EU will explore the future of model-informed drug development through unique customer case studies, insights, and best practices. Read the full announcement: https://lnkd.in/eFbmp-Vt #CertaintyEU #CertaintybyCertara #DrugDevelopment